Evidence map›Paper›PMID 40650182›Full record

ReviewInternational journal of molecular sciences2025

Modulation of Endoplasmic Reticulum Stress in Experimental Anti-Cancer Therapy.

Natalia Ivanovna Agalakova

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Multi-omics integration identifiesTranslational andrology and urology · 2026
    Article
  3. Article
  4. Article
  5. Subcellular Stress Markers in Epithelial Ovarian Cancer.International journal of molecular sciences · 2025
    Review
  6. Enhancing Cytosolic Internalization of [International journal of molecular sciences · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Natalia Ivanovna AgalakovaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Avenue, Saint-Petersburg 194223, Russia.ORCID 0000-0002-0393-8139

Funding

free disccount free discount
6 · The paper itself

Abstract

The growth of tumor cells is accompanied by an increased rate of endoplasmic reticulum stress (ERS), the accumulation of misfolded proteins, and the activation of a network of adaptive signaling pathways known as the unfolded protein response (UPR). Although the UPR is an adaptive reaction aiming to restore ER proteostasis, prolonged and severe ERS leads to cell death. Taking into account that the components of the ERS/UPR machinery in cancers of different types can be overexpressed or downregulated, both the induction of excessive ERS and suppression of UPR have been proposed as therapeutic strategies to sensitize cells to conventional chemotherapy. This narrative review presents a several examples of using natural and synthetic compounds that can either induce persistent ERS by selectively blocking ER Ca

Indexed as

Antineoplastic AgentsEndoplasmic Reticulum StressNeoplasmsAnimalsEndoplasmic Reticulum Chaperone BiPHumansSignal TransductionUnfolded Protein ResponseAntineoplastic AgentsEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanATF6 inhibitorscancer cellsendoplasmic reticulum stressGRP78 inhibitorsIRE1α inhibitorsPERK inhibitorsSERCA inhibitorsunfolded protein response

Identifiers

PMID40650182
PMCPMC12250421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.